Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
The Utilization, Reimbursement, and Cost of Targeted Therapies for Duchenne Muscular Dystrophy (DMD) in US Medicaid Programs: A Descriptive Trend Analysis from 2017 to 2022.
Journal: Pharmaceutical medicine
Published: September 09, 2025
Evolution and Breakthroughs in Exon Skipping and Splice Modulation: From Inception to Clinical Success.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
Exon-Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2025
Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis.
Journal: Journal of comparative effectiveness research
Published: July 18, 2025
Antisense oligonucleotide as novel therapies for neurogenetic disorders
Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: January 08, 2025
Givinostat (Duvyzat) for Duchenne muscular dystrophy.
Journal: The Medical letter on drugs and therapeutics
Published: January 06, 2025
Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseases.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 04, 2025
Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis.
Journal: Advances in therapy
Published: August 28, 2024
Correction to: Evolving Role of Viltolarsen for Treatment of Duchenne Muscular Dystrophy.
Journal: Advances in therapy
Published: August 02, 2024
Safety and efficacy of viltolarsen treatment in patients with Duchenne muscular dystrophy: A retrospective study with 3-year follow-up.
Journal: Brain & development
Published: July 07, 2024
Last Updated: 10/31/2025